Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

BackgroundThyroid hormone impairment, represented as an alteration in levels of thyroid hormones and a lower fT3/fT4 ratio, has been correlated with a worse prognosis for both cancer and non-cancer patients. The role of baseline thyroid function in patients with metastatic renal cell carcinoma (mRCC...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, Michele Dionese, Sebastiano Buti, Luca Galli, Andrea Zivi, Sara Watutantrige-Fernando, Teresa Zielli, Elisa Zanardi, Roberto Sabbatini, Umberto Basso, Vittorina Zagonel, Giuseppe Procopio
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
renal cell carcinoma
FT3/FT4
deiodination
tyrosine kinase inhibitors
immunotherapy
progression
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/9a3e4a93738845bf87bc0203274f79b2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/9a3e4a93738845bf87bc0203274f79b2

Similar Items